Back

Effect of finerenone on cardiac remodeling and exercise capacity in patients with anterior ST-elevation myocardial infarction underwent primary percutaneous coronary intervention

30 August 2026 (15:15 - 15:45)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury Aldosterone Antagonists ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Safir Sungkar

Dr. Kariadi Central Hospital, Semarang (Indonesia)

3 More presentations in this session

Presentation thumbnail
Comparative effectiveness of mineralocorticoid receptor antagonists in cardiorenal and metabolic disease
Associate Professor A. Briasoulis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Development and validation of a Frusemide Card to guide self-titration of oral frusemide in the outpatient setting
Doctor S. Hussin (Kota Bharu, MY)
Abstract Slides Video
Presentation thumbnail
Effect of coramitug on diuretic use in transthyretin amyloid cardiomyopathy (ATTR CM): a post-hoc analysis from a phase 2 randomised, placebo-controlled study
Professor S. Gottlieb (Baltimore, US)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy of aldosterone signalling and drug‑related myocardial injury

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
FINEARTS-HF - Finerenone in heart failure with mildly reduced and preserved ejection fraction
1 September 2024
thumbnail
Congress Presentation
Cardiac power as an integrative hemodynamic marker of risk stratification and ventricular dysfunction following acute myocardial infarction
28 August 2026
thumbnail
Congress Presentation
Fractalkine Inhibition in Acute Myocardial Infarction leads to reduced intramyocardial haemorrhage
1 September 2024
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitor enhances mitochondrial stress resistance without altering ATP production in patients with ST-elevation myocardial infarction
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources